• There are no suggestions because the search field is empty.

EU-QPPV registration and local pharmacovigilance contacts: what you need to know

Calander_icon
person-image
Gorka Ibaibarriaga Ruiz, Senior Consultant Drug Safety

Understand the process for EU-QPPV registration and the role of local pharmacovigilance contacts to ensure compliance with European Union regulations. 

EU-QPPV registration and local pharmacovigilance contacts
3:55

In the European Union, ensuring the safety of human pharmaceutical products requires strict compliance with pharmacovigilance regulations. At the heart of this system is the Qualified Person Responsible for Pharmacovigilance (QPPV) 

This role, established under Article 23 of Regulation (EC) No 726/2004, is critical to maintaining a compliant pharmacovigilance system for products marketed in the EU. 

What is a(n) (EU-)QPPV? 

The EU-QPPV is a mandatory role for any holder of a marketing authorization for human-use drugs. This individual, typically an employee of the pharmaceutical company, is responsible for ensuring that pharmacovigilance systems operate effectively and comply with EU safety regulations. 

When submitting a marketing authorization application, companies must provide: 

  • A description of their pharmacovigilance system, outlining how they will monitor product safety during real-world use. 
  • Proof of a QPPV’s appointment, ensuring the role is permanently and continuously available. 

As the regulation states: 

"The holder of an authorization for a medicinal product for human use granted in accordance with the provisions of this Regulation shall have permanently and continuously at their disposal an appropriately qualified person responsible for pharmacovigilance." 

How to register an EU-QPPV 

Navigating the registration process for a QPPV or transitioning to a new QPPV can seem complex, but the European Medicines Agency (EMA) provides clear guidance. 

Steps to register or change a QPPV: 

  1. New Registration 
    Companies must submit detailed information about the candidate's qualifications, experience, and responsibilities to demonstrate their capability for the role. 
  1. Change of QPPV 
    Seamlessly transitioning to a new QPPV involves adhering to specific EMA procedures to maintain regulatory compliance. 

Detailed guidance on these processes is available on the EMA website: EMA QPPV Registration Guidance. 

Local pharmacovigilance contacts in EU member states 

In addition to the EU-QPPV, some EU member states require local pharmacovigilance contacts to bridge communication between companies and national health authorities. These contacts ensure that country-specific pharmacovigilance requirements are fulfilled. 

Key considerations for local pharmacovigilance contacts: 

  • Requirement by Country: Not all EU member states require local pharmacovigilance contacts. Detailed requirements for each country are provided by the EMA: Local Contact Requirements. 
  • Steps to Nominate: In countries where local contacts are needed, companies must follow the specified steps, including providing detailed information about the individual’s qualifications and responsibilities. 

Why choose QbD Group for QPPV and local contact support? 

At QbD Group, we have extensive experience in supporting pharmaceutical companies with QPPV registration and the nomination of local pharmacovigilance contacts. With our team of experts, you can: 

  • register or transition a QPPV with confidence. 
  • navigate country-specific requirements for local pharmacovigilance contacts. 
  • anticipate and address regulatory challenges with comprehensive solutions. 

Our experience and guidance ensure you’re always prepared for compliance audits and inspections. 

Conclusion: compliance made simple 

Compliance with EU pharmacovigilance regulations starts with appointing a qualified QPPV and, where necessary, nominating local pharmacovigilance contacts. These steps are critical to protecting patient safety and maintaining regulatory approval for your products. 

At QbD Group, we simplify this process. From registration to regulatory guidance, we’re here to help you every step of the way.  

Ready to streamline your pharmacovigilance compliance? Contact QbD Group today to schedule a consultation with our experts.

 

Stay ahead in life sciences

Keeping up with the fast-paced life sciences industry doesn’t have to be overwhelming.

Our newsletter delivers the latest insights, industry updates, and expert content directly to your inbox, helping you stay informed and make smarter decisions.

Circles-banner-short

Discover more expert content

preview_image
Webinar

Pharmacovigilance and Risk Management in Innovative Therapies: A Challenge in Drug Safety

Explore pharmacovigilance in cell, CAR T, and RNA therapies. Join our webinar to tackle tomorrow’s drug safety and risk management challenges.
preview_image
Webinar

Unlocking Strategic Value in Drug Safety for Life Sciences Organizations

Explore how drug safety teams can transform into proactive benefit drivers with the right tools & resources in this webinar on demand.
preview_image
Whitepaper

The One-Vigilance strategic roadmap to corporate excellence

This whitepaper introduces the concept of One Vigilance within the context of the current drug safety landscape. Download now.
preview_image
Whitepaper

Ensuring compliance and quality in Pharmacovigilance

The whitepaper emphasizes the importance of a robust pharmacovigilance QMS and a well-maintained Pharmacovigilance System Master File (PSMF). Download now.
preview_image
Case study

Optimizing pharmacovigilance for a biotechnology leader

Discover how QbD Group improved pharmacovigilance for a global leader in biotechnology, ensuring regulatory compliance and patient safety.
preview_image
Case study

Revolutionizing pharmacovigilance: a success story of strategic partnership and seamless integration

Discover how QbD Group's expert support enhanced a pharmaceutical company's pharmacovigilance, leading to a favorable inspection outcome by the local Regulatory Authority (AEMPS).
preview_image
Case study

Patient Support Program (PSP)

Learn about our patient support program (PSP) and how it helps manage customer support for a PV Spanish client. Resolve quality issues and ensure stability with QbD Pharma.